coldchain_liu
TL3 Regular · Vancouver, CA
Cold chain validation for clinical supplies. Phase-change packs, mean kinetic temperature, and why a warm parcel is not automatically a ruined one.
Joined 12 December 2024 · last posted 5d · groups: wiki-editors
138 posts, newest first. Showing up to 150.
-
Programming during a large energy deficit Replied, post #47 · Nutrition & Training › Resistance training · 23 Jul 2026 · 10 likes Coming back to post #45, because the follow-up matters more than the original answer. Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable…
-
Immortal time bias in a claims-database study — one year on Replied, post #36 · Evidence › Study critique · 21 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Seven-day rolling means and why weekly readings mislead Replied, post #56 · Outcomes › Progress reports · 18 Jul 2026 · 0 likes Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
-
Why the timeline is on the right and not the left — what changed since Replied, post #76 · Meta › Site feedback · 17 Jul 2026 · 0 likes Coming back to post #74, because the follow-up matters more than the original answer. Guideline clarity: if the guidelines are unclear or seem to be applied…
-
A site rotation scheme that is easy enough to actually follow Replied, post #117 · Practice › Administration · 17 Jul 2026 · 16 likes This follows post #114 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
What to bring: records that a clinician can actually use Replied, post #3 · Clinical › Prescriber conversations · 16 Jul 2026 · 11 likes post #2 answers the question as asked. The question underneath it is different. Prescription logistics: confirm whether it will be filled locally, requires mail order,…
-
Follow-up: UK access routes, dated and sourced Replied, post #12 · Regional › UK & Ireland · 16 Jul 2026 · 6 likes post #11 is right about the mechanism and I think understates the practical bit. MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #39 · Analytics › HPLC & UHPLC · 15 Jul 2026 · 1 like Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #12 · Analytics › Impurities & related substances · 15 Jul 2026 · 0 likes post #11 is right about the mechanism and I think understates the practical bit. Residual solvents: traces of solvents used in purification. These are usually tested by…
-
Semaglutide and alcohol: what is actually documented Replied, post #16 · Compounds › Semaglutide · 13 Jul 2026 · 29 likes This follows post #13 rather than contradicting it. The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #63 · Evidence › Journal club · 11 Jul 2026 · 2 likes Picking up post #60: that is the part I would want checked first. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #20 · Compounds › Repair & healing peptides · 8 Jul 2026 · 16 likes Worth separating two things that post #16 runs together. What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised…
-
Does a peptide degrade silently, with no visual change? Replied, post #63 · Practice › Storage & stability · 5 Jul 2026 · 28 likes Coming back to post #61, because the follow-up matters more than the original answer. Dating prepared solutions: write the date reconstitution on the vial in permanent…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #38 · Compounds › Retatrutide · 5 Jul 2026 · 33 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #30 · Practice › Reconstitution · 4 Jul 2026 · 15 likes I read post #28 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #94 · Analytics › HPLC & UHPLC · 1 Jul 2026 · 18 likes Coming back to post #92, because the follow-up matters more than the original answer. Gradient slope is the single biggest driver of apparent purity differences. A…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #43 · Analytics › Home & field testing · 1 Jul 2026 · 13 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #32 · Analytics › Home & field testing · 27 Jun 2026 · 13 likes I read post #30 twice before replying, because I had assumed the opposite. Enzyme assays: if you have an enzyme that reacts specifically with your compound, an…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #75 · Analytics › HPLC & UHPLC · 26 Jun 2026 · 0 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #22 · Analytics › Impurities & related substances · 24 Jun 2026 · 0 likes Picking up post #19: that is the part I would want checked first. Related substances: compounds chemically related to the target peptide but not the target peptide…
-
Spreadsheets: an appreciation — what changed since Replied, post #79 · Lounge › Off topic · 23 Jun 2026 · 24 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #12 · Practice › Dosing & titration · 23 Jun 2026 · 27 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
A site rotation scheme that is easy enough to actually follow Replied, post #95 · Practice › Administration · 22 Jun 2026 · 30 likes On post #91 — agreed on the reasoning, with one qualification. Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #123 · Practice › Reconstitution · 22 Jun 2026 · 0 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Submitting a sample: the process end to end Replied, post #31 · Sourcing › Independent verification · 22 Jun 2026 · 11 likes I read post #29 twice before replying, because I had assumed the opposite. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials.…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #27 · Compounds › Secretagogues & GH axis · 20 Jun 2026 · 19 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
-
Revisiting: What pooling buys you and what it destroys Replied, post #56 · Evidence › Meta-analyses · 15 Jun 2026 · 31 likes post #55 is right about the mechanism and I think understates the practical bit. Study quality and weighting: some meta-analyses weight all studies equally; others…
-
Cold solution and stinging: the simplest fix Replied, post #34 · Practice › Administration · 11 Jun 2026 · 12 likes This follows post #31 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Constipation management, with a dietitian's contribution Replied, post #77 · Practice › Side effects · 10 Jun 2026 · 1 like Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
When a dose reduction is the correct response to a side effect Replied, post #27 · Practice › Dosing & titration · 6 Jun 2026 · 19 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
What to include when your question involves a chromatogram — one year on Replied, post #28 · Start Here › How to Ask · 6 Jun 2026 · 0 likes Coming back to post #26, because the follow-up matters more than the original answer. Disagreeing with an answer you got: cite what you disagree with, say what…
-
Injecting into an area that has become firm: why not to Replied, post #3 · Practice › Administration · 1 Jun 2026 · 10 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Step therapy requirements and how to satisfy them Replied, post #25 · Access › Insurance & coverage · 25 May 2026 · 0 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #66 · Compounds › Tirzepatide · 19 May 2026 · 16 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
What a certificate commits its issuer to — the long version Replied, post #4 · Analytics › COA interpretation · 1 May 2026 · 0 likes Worth separating two things that post #3 runs together. What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated…
-
The most useful thing you learned here that was not the answer you came for Replied, post #37 · Lounge › Off topic · 24 Apr 2026 · 22 likes post #36 is right about the mechanism and I think understates the practical bit. Lower-stakes conversation that does not belong in the technical categories. Still…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #45 · Practice › Administration · 10 Apr 2026 · 0 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #60 · Practice › Administration · 6 Apr 2026 · 9 likes On post #56 — agreed on the reasoning, with one qualification. Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #32 · Compounds › Repair & healing peptides · 4 Apr 2026 · 0 likes Picking up post #29: that is the part I would want checked first. Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity…
-
Grapefruit: why this class is not the class that cares Replied, post #81 · Practice › Interactions · 26 Mar 2026 · 14 likes Coming back to post #79, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #4 · Compounds › Oral incretins · 23 Mar 2026 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #34 · Practice › Administration · 22 Mar 2026 · 19 likes post #33 is right about the mechanism and I think understates the practical bit. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer…
-
The "under review" status pill and when a moderator applies it Replied, post #21 · Evidence › Preprints · 15 Mar 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #53 · Lounge › Introductions · 13 Mar 2026 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #37 · Practice › Administration · 13 Mar 2026 · 6 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Guidelines revision: what changed and why — one year on Replied, post #81 · Meta › Announcements · 12 Mar 2026 · 0 likes Picking up post #78: that is the part I would want checked first. Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #12 · Meta › Announcements · 5 Mar 2026 · 0 likes Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will explain their reasoning.
-
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #5 · Practice › Dosing & titration · 3 Mar 2026 · 0 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
What I would record differently if I started again Replied, post #2 · Outcomes › Progress reports · 3 Mar 2026 · 11 likes I read the opening post twice before replying, because I had assumed the opposite. Measurement noise: day-to-day body mass varies by more than a kilogram on hydration,…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #24 · Research Methods › N-of-1 designs · 1 Mar 2026 · 19 likes I read post #22 twice before replying, because I had assumed the opposite. When to run an n-of-1: this design works when you want to know whether a treatment works for…
-
Research-use-only status: what it means legally and practically Replied, post #7 · Compounds › Other compounds · 22 Feb 2026 · 4 likes Coming back to post #5, because the follow-up matters more than the original answer. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds…
-
Personal import allowances, compared — a second dataset Replied, post #73 · Access › International · 22 Feb 2026 · 0 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
Coming back to: Time to steady state after a dose increase Replied, post #4 · Pharmacology › Pharmacokinetics · 21 Feb 2026 · 2 likes Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance.
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #117 · Practice › Dosing & titration · 21 Feb 2026 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #27 · Practice › Interactions · 20 Feb 2026 · 9 likes post #26 is right about the mechanism and I think understates the practical bit. Thyroid medications: semaglutide is associated with a slowing of gastric emptying,…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #72 · Outcomes › Progress reports · 17 Feb 2026 · 1 like This follows post #69 rather than contradicting it. Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #14 · Practice › Dosing & titration · 15 Feb 2026 · 12 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
Trifluoroacetate content and its consequences Replied, post #111 · Analytics › Impurities & related substances · 8 Feb 2026 · 17 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Trifluoroacetate content and its consequences Replied, post #106 · Analytics › Impurities & related substances · 8 Feb 2026 · 2 likes I read post #104 twice before replying, because I had assumed the opposite. Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue.…
-
Personal import allowances, compared — a second dataset Replied, post #64 · Access › International · 6 Feb 2026 · 16 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #74 · Pharmacology › Pharmacokinetics · 3 Feb 2026 · 24 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Heterogeneity as information rather than as a nuisance Replied, post #77 · Evidence › Meta-analyses · 26 Jan 2026 · 8 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Pen dose counters: what a click does and does not guarantee Replied, post #4 · Devices › Pens & autoinjectors · 26 Jan 2026 · 4 likes Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming you have the correct pen before injection prevents administration…
-
Follow-up: Search filters: what is missing Replied, post #19 · Meta › Site feedback · 22 Jan 2026 · 13 likes On post #15 — agreed on the reasoning, with one qualification. Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #62 · Pharmacology › Receptor biology · 17 Jan 2026 · 12 likes Species differences: rodent studies show the same compounds produce effects in rodents that predict human effects reasonably well for semaglutide and tirzepatide. The…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #53 · Analytics › Method validation · 7 Jan 2026 · 18 likes I read post #51 twice before replying, because I had assumed the opposite. Robustness: the method gives consistent results when minor parameters vary. Tested by…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #34 · Compounds › Tirzepatide · 30 Dec 2025 · 31 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #5 · Practice › Storage & stability · 24 Dec 2025 · 4 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
Prescription requirements and telehealth models Replied, post #85 · Sourcing › Regulatory · 23 Dec 2025 · 12 likes I read post #83 twice before replying, because I had assumed the opposite. Approval versus licensing: a compound can be approved for a specific indication in one…
-
Early satiety becoming a problem rather than a benefit Replied, post #12 · Practice › Side effects · 1 Dec 2025 · 0 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #23 · Access › Pricing · 25 Nov 2025 · 0 likes Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These…
-
Robustness: the parameters worth deliberately varying Replied, post #19 · Analytics › Method validation · 24 Nov 2025 · 0 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
What pooling buys you and what it destroys Replied, post #68 · Evidence › Meta-analyses · 16 Nov 2025 · 11 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Sleep quality changes during weight loss — what changed since Replied, post #62 · Wellbeing › Sleep · 13 Nov 2025 · 26 likes Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing (morning versus evening) might help if nighttime GI…
-
Reading SURMOUNT-1 without the press release Replied, post #57 · Compounds › Tirzepatide · 6 Nov 2025 · 0 likes On post #53 — agreed on the reasoning, with one qualification. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #50 · Compounds › Tirzepatide · 21 Oct 2025 · 2 likes Worth separating two things that post #46 runs together. Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #55 · Compounds › Other compounds · 26 Sep 2025 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #104 · Compounds › Oral incretins · 19 Sep 2025 · 20 likes Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual variation is larger than with injectables and is…
-
Reading SURMOUNT-1 without the press release Replied, post #2 · Compounds › Tirzepatide · 3 Sep 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
When a preprint is the best available evidence and we say so Replied, post #63 · Evidence › Preprints · 16 Aug 2025 · 0 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
[2026 update] Heterogeneity as information rather than as a nuisance Replied, post #5 · Evidence › Meta-analyses · 14 Aug 2025 · 0 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #105 · Compounds › Tirzepatide · 13 Aug 2025 · 31 likes Picking up post #102: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #39 · Analytics › Mass spectrometry · 8 Aug 2025 · 1 like Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
EU-wide position versus national implementation Replied, post #19 · Regional › European Union · 20 Jul 2025 · 26 likes post #18 is right about the mechanism and I think understates the practical bit. Reimbursement varies substantially by member state. Some (Germany, France, Netherlands)…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #48 · Data & Tools › Calculators · 11 Jul 2025 · 16 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Pages past their review date, listed Started this topic · Meta › Wiki maintenance · 24 Jun 2025 · 29 likes Pages past their review date, listed Writing it up because I had to work it out twice and would rather nobody else did. Nominating something for promotion into the…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #56 · Evidence › Journal club · 22 Jun 2025 · 12 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Why the timeline is on the right and not the left Replied, post #31 · Meta › Site feedback · 20 Jun 2025 · 28 likes Worth separating two things that post #27 runs together. Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #33 · Compounds › Semaglutide · 19 Jun 2025 · 11 likes post #32 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #40 · Pharmacology › Pharmacokinetics · 11 Jun 2025 · 6 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
-
Counter-ion content and its effect on measured mass Replied, post #54 · Analytics › Mass spectrometry · 2 Jun 2025 · 14 likes Resolution: "high resolution" commonly means
-
Regression to the mean in progress reports Replied, post #13 · Research Methods › Statistics · 25 May 2025 · 0 likes I read post #11 twice before replying, because I had assumed the opposite. Power and sample size: a study might be too small to detect a real effect (low power). Sample…
-
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #24 · Clinical › Bloodwork · 24 May 2025 · 18 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Reading a trial's population section before its results — does this still hold? Replied, post #136 · Evidence › Trials · 23 May 2025 · 6 likes post #135 answers the question as asked. The question underneath it is different. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #45 · Research Methods › N-of-1 designs · 22 May 2025 · 13 likes Coming back to post #43, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Travel coolers and how long they really hold — the long version Replied, post #7 · Devices › Cold chain · 20 May 2025 · 0 likes Travel with medication: carrying a vial across borders requires planning if temperatures will exceed the range or if journey time is long. Insulated travel cases with…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #30 · Evidence › Trials · 15 May 2025 · 17 likes This follows post #27 rather than contradicting it. Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the…
-
A supplier that answers analytical questions with restated claims Replied, post #69 · Sourcing › Red flags · 3 May 2025 · 1 like post #68 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Relative retention time as a better inter-laboratory comparator Replied, post #5 · Analytics › Method validation · 28 Apr 2025 · 15 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
-
EU-wide position versus national implementation Replied, post #2 · Regional › European Union · 27 Apr 2025 · 8 likes Italy: AIFA controls reimbursement through a note system. Weight-management indications have not attracted public reimbursement. Regional health authorities add further…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #133 · Evidence › Journal club · 23 Apr 2025 · 24 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Requesting a page: what makes a good request Replied, post #60 · Documentation › Wiki requests · 17 Apr 2025 · 0 likes On post #56 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #18 · Data & Tools › Calculators · 15 Apr 2025 · 14 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #41 · Compounds › Secretagogues & GH axis · 12 Apr 2025 · 0 likes Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth hormone level is nearly uninterpretable. Assessing…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #12 · Evidence › Journal club · 6 Apr 2025 · 4 likes Picking up post #9: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #40 · Wellbeing › Mental health · 5 Apr 2025 · 0 likes On post #36 — agreed on the reasoning, with one qualification. Identity and self-image: for some people, weight and body size are central to identity. Large change to…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #48 · Analytics › Mass spectrometry · 28 Mar 2025 · 21 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Follow-up: Review cadence: how often is a page actually re-checked? Replied, post #2 · Documentation › Doc review · 27 Mar 2025 · 3 likes This follows the opening post rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #114 · Analytics › COA interpretation · 23 Mar 2025 · 8 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #113 · Sourcing › Vendor reports · 18 Mar 2025 · 12 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #77 · Evidence › Journal club · 14 Mar 2025 · 0 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Scheduled maintenance and what will be unavailable Replied, post #64 · Meta › Announcements · 6 Mar 2025 · 1 like This follows post #61 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Follow-up: What other technical communities get right that we do not Replied, post #31 · Lounge › Off topic · 4 Mar 2025 · 7 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Consistent declarations and why they matter more than clever ones Replied, post #80 · Sourcing › Logistics · 24 Feb 2025 · 0 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Consistent declarations and why they matter more than clever ones Replied, post #65 · Sourcing › Logistics · 21 Feb 2025 · 9 likes I read post #63 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #45 · Compounds › Secretagogues & GH axis · 20 Feb 2025 · 2 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
-
A promotion I argued against, and why I lost Replied, post #99 · Documentation › Doc review · 16 Feb 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #28 · Practice › Reconstitution · 2 Feb 2025 · 12 likes Picking up post #25: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #54 · Compounds › Cagrilintide & amylin analogues · 22 Jan 2025 · 11 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
When to suspect the method rather than the sample Replied, post #68 · Analytics › Method validation · 19 Jan 2025 · 16 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Recovery when intake is low: what to cut first Replied, post #62 · Nutrition & Training › Resistance training · 13 Jan 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: Individual participant data versus aggregate data Replied, post #56 · Evidence › Meta-analyses · 10 Jan 2025 · 30 likes Coming back to post #54, because the follow-up matters more than the original answer. Sensitivity analysis: the authors re-run the meta-analysis excluding studies one…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #154 · Compounds › Oral incretins · 29 Dec 2024 · 25 likes Picking up post #151: that is the part I would want checked first. Trial adherence in an oral trial with strict administration requirements is genuinely worse than…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #74 · Compounds › Semaglutide · 23 Dec 2024 · 0 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #158 · Analytics › COA interpretation · 20 Dec 2024 · 2 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Body image changing more slowly than the body Replied, post #62 · Wellbeing › Mental health · 18 Dec 2024 · 27 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #74 · Access › Insurance & coverage · 17 Dec 2024 · 26 likes On post #70 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #57 · Evidence › Journal club · 11 Dec 2024 · 32 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Fibre intake when total intake falls, and the constipation link Replied, post #3 · Nutrition & Training › Protein & intake · 29 Nov 2024 · 2 likes Worth separating two things that the opening post runs together. Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the…
-
Revisiting: Moderation log format change Replied, post #43 · Meta › Announcements · 26 Nov 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #20 · Clinical › Special populations · 20 Nov 2024 · 8 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
EMA product information as a primary source — does this still hold? Replied, post #117 · Regional › European Union · 18 Nov 2024 · 20 likes Private prescription with self-payment is legal across the EU and is the common route where public reimbursement is not available.
-
EMA product information as a primary source — does this still hold? Replied, post #81 · Regional › European Union · 17 Nov 2024 · 0 likes Spain: AEMPS is the regulator. Public reimbursement for weight management has been limited with regional variation in specialist pathways. Private prescription is common.
-
EMA product information as a primary source — does this still hold? Replied, post #62 · Regional › European Union · 16 Nov 2024 · 3 likes France: ANSM implements EU framework. Reimbursement has been narrower for weight management. Prescribing restrictions were applied during shortages, directing available…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #24 · Compounds › Semaglutide · 13 Nov 2024 · 10 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Why "any advice?" is the least effective ending for a post Replied, post #13 · Start Here › How to Ask · 6 Nov 2024 · 12 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #17 · Sourcing › Regulatory · 30 Oct 2024 · 0 likes post #16 is right about the mechanism and I think understates the practical bit. Why this category is maintained as documentation, not as recommendations: the goal is…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #3 · Evidence › Journal club · 5 Jul 2024 · 0 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…